| Document |
Document Title |
|
WO/1995/033735A1 |
Described are epoxycyclopentane derivatives of general formula (I) in which R1 is an alkyl group with 1 to 8 C-atoms and R2 is an alkyl group with 1 to 4 C-atoms. Such compounds are fragrances with unusual scents, high adherent strength ...
|
|
WO/1995/032954A1 |
The present invention relates to a compound of formula (I), wherein R1 stands for an optionally esterified or amidated carboxyl group, X stands for an optionally substituted divalent hydrocarbon residue, R2 stands for hydrogen or an opti...
|
|
WO/1995/032940A1 |
The present invention concerns a method for the production of olefin anhydrides, such as acrylic anhydride and methacrylic anhydride, via reactions between an aromatic acid chloride, such as benzoyl chloride, and carboxylate ions of the ...
|
|
WO/1995/031450A1 |
A process for synthesizing enantiomerically pure chiral secondary alcohol compounds linked to a heterocyclic core moiety, using a natural chiral molecule starting material. The inventive process is particularly useful for bulk manufactur...
|
|
WO/1995/031511A1 |
A composition comprising water and the following components: (a) an epoxy compound comprising at least one epoxy group and at least one nitrogen atom; and (b) a carboxy functional polymer, a hydroxy functional polymer, a polymer having c...
|
|
WO/1995/030650A1 |
The invention relates to borneol derivatives of the general formula (I) in which R1 is C(O)-CH(OR6)-CH(NHR7)-R8, R2 is hydrogen, -OH, C1-C10-Alkyl, C1-C10-alkoxy, -OC(O)R9b, -OP(O)(OH)2 or R2 and R3 are together an oxygen atom, R4 is hyd...
|
|
WO/1995/028374A1 |
A novel glycerol derivative and a process for producing the same, and a process for producing a triazole derivative. Specifically the invention provides an optically active 2-arylglycerol derivative that is novel and useful as an interme...
|
|
WO/1995/026960A1 |
A physiologically active substance EI-1507 represented by general formula (I), wherein X and Y are combined together to represent oxygen, or each independently represents hydrogen or hydroxyl.
|
|
WO/1995/025762A1 |
A semi-crystalline polyglycidylester obtainable by glycidation of the acid groups of a semi-crystalline acid functional polyester the latter being a reaction product of at least compound(s) A and compound(s) B, wherein compound A is a st...
|
|
WO/1995/024267A1 |
A metallomacrocycle catalyst composition comprising a complex of: (i) a transition metal catalyst selected from: (a) a transition metal porphin and mixtures thereof; (b) a transition metal phthalocyanine and mixtures thereof; (c) mixture...
|
|
WO/1995/024401A2 |
The invention relates to a process for preparing 1,2-butylene oxide by the catalytic hydrogenation of vinyl oxirane on a heterogeneous catalyst by using a catalyst which contains an element from the Ist, VIIth or VIIIth subgroup of the p...
|
|
WO/1995/024393A1 |
A compound of formula (I) wherein, R1 is carboxy or protected carboxy; R2 is hydrogen, hydroxy or protected hydroxy; R3 is hydrogen, hydroxy, protected hydroxy, etc.; R4 is hydrogen or halogen; A1 is lower alkylene; A2 is bond or lower a...
|
|
WO/1995/023794A2 |
Glycidyl esters are prepared to have low chlorine, chloride, sodium and potassium contamination and a thixotropic index greater than 3.0 by a process that comprises reacting carboxylic mono- or dimer acids with glycidyl alcohols in a mol...
|
|
WO/1995/021172A1 |
A process for enantioselectively epoxidising a prochiral olefin, which process comprises reacting the prochiral olefin with a source of oxygen in the presence of a salen catalyst and a source of an electron donating ligand, characterised...
|
|
WO/1995/019765A1 |
Novel compounds for use in inhibiting fatty acid synthesis are disclosed. The compounds can be used for the treatment of tumors or microbial infections.
|
|
WO/1995/018119A1 |
A novel compound F-10463a represented by formula (I). It is useful as an anti-HIV drug, antidiabetic, antiarteriosclerotic, antiosteoporotic, antithrombotic, anti-inflammatory, immunosuppressant, diuretic, and a preventive or remedy for ...
|
|
WO/1995/018120A1 |
Compounds of Formula (1) where R1-R7 are hydrogen, lower alkyl of 1-6 carbons, or halogen; Y is phenyl, pyridyl, furyl, thienyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl ou oxazolyl; A is (CH2)n, where n is 0-5, lower branched chai...
|
|
WO/1995/017445A1 |
A reaction between: (1) a compound that contains one or more epoxide moieties per molecule, and (2) a compound that contains one or more primary aliphatic hydroxyl groups per molecule; is catalyzed by: (3) trifluoromethanesulfonic acid o...
|
|
WO/1995/017093A1 |
The present invention provides novel cryptophycin compounds having structure (I). The present invention also provides methods for producing cryptophycins from the Nostoc sp. of blue-green algae (cyanobacteria). Pharmaceutical composition...
|
|
WO/1995/017481A1 |
Fluorine-containing, chiral liquid crystal compounds comprise: a) an aliphatic fluorocarbon terminal portion containing at least two catenary ether oxygen atoms; b) a chiral, aliphatic hydrocarbon terminal portion; and c) a central core ...
|
|
WO/1995/014652A1 |
The invention relates to novel triphenylene compounds containing at least three ethylenically unsaturated groupings, oxiranyl or thiiranyl group-bearing groupings bonded to the triphenylene backbone, and a process for producing discoidal...
|
|
WO/1995/014653A1 |
A synthesis is described for intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors. The method includes forming a diastereoselective epoxide of cyanohydrin from a...
|
|
WO/1995/013263A1 |
The invention relates to phenyl propane derivatives of general formulae (I) or (II) or (III) or (IV) or (V) or mixtures thereof, wherein R1 and R2 are branched or straight-chain alkyl groups of general formula CnH2n+1, wherein n=1-18, fo...
|
|
WO/1995/011230A1 |
A process for the preparation of an oxirane, aziridine or cyclopropane of formula (I) wherein, X is oxygen, NR4 or CHR5; R1 is hydrogen, alkyl, aryl, heteroaromatic, heterocyclic or cycloalkyl; R2 is hydrogen, alkyl, aryl, heteroaromatic...
|
|
WO/1995/009849A1 |
Disclosed are improved processes for the recovery of 3,4-epoxy-1-butene (EpB) from an epoxidation effluent comprising EpB, butadiene, oxygen and butane obtained by the selective epoxidation of butadiene with an oxygen-containing gas in t...
|
|
WO/1995/009850A1 |
Disclosed herein is an improved gas phase process for the selective epoxidation of non-allylic olefins wherein the epoxidation is carried out in the presence of certain inert, paraffin hydrocarbons. Such hydrocarbons possess higher heat ...
|
|
WO/1995/009379A1 |
The invention is in the field of retardation layers comprising high-molecular weight liquid-crystalline material for liquid-crystalline displays. The invention is directed to a retardation layer for a liquid-crystalline display comprisin...
|
|
WO/1995/008546A1 |
An epoxycyclohexenedione derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R represents C10-C25 linear or branched alkanoyl, C10-C25 linear alkenoyl or a group represented by formula (A...
|
|
WO/1995/008545A1 |
Manufacturing ethylene oxide comprises allowing to react in a reactor (2) ethylene and free oxygen-containing gas to ethylene oxide in the presence of methane, argon and carbon dioxide; withdrawing from the reactor (2) a reactor effluent...
|
|
WO/1995/007896A1 |
Novel hydroxy ethyl azolyl derivatives of formula (I), in which: X is hydrogen, halogen, alkyl with 1 to 4 carbon atoms or alkoxy with 1 to 4 carbon atoms; Z is halogen, alkyl with 1 to 4 carbon atoms, halogen alkyl with 1 to 4 carbon at...
|
|
WO/1995/007269A1 |
The invention relates to retroviral protease inhibitors of the general formula (I): W-(A)n-B-(A*)m-V where W, A, B, A*, V, n and m are as defined herein, including related prodrugs of general formula (I) comprising a solubilising group w...
|
|
WO/1995/006631A1 |
Arthropodicidal compounds, compositions and use of compounds having Formula (I), wherein A is selected from the group H, CN, C1-C6 alkyl, C1-C6 haloalkyl and halogen; E is selected from the group H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 al...
|
|
WO/1995/005370A1 |
A process for the epoxidation of alkenes is provided. The process comprises contacting the alkene with a solution of partially neutralised Caro's acid in the presence of a ketone at a pH of from 7 to 8.5. Preferably, the ketone is select...
|
|
WO/1995/004036A1 |
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to membe...
|
|
WO/1995/002587A1 |
Compounds of formula (I) are oxytocin antagonists useful in the treatment of preterm labor, dysmenorrhea and for the stoppage of labor preparatory to ceasarean delivery.
|
|
WO/1995/002631A1 |
Continuous fiber reinforced oriented mesogen-containing resin matrix composites are prepared by (A) saturating a continuous fiber substrate material with a curable composition comprising (1) at least one mesogen-containing resin which co...
|
|
WO/1995/002583A1 |
Intermediates of structural formula (A) can be made by reacting a primary or secondary amine with glycosidol or an activated derivative thereof. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.
|
|
WO/1995/002566A1 |
The present invention relates to an array of compounds having a common core structure wherein the compounds of the array comprise the products of a multiple component combinatorial array synthesis having at least three components. The pr...
|
|
WO/1994/029402A1 |
Refrigerant compositions include mixtures of perfluorooxetane and perfluoromethyl ethyl ether or dimethyl ether; 2,2,4,4,5,5-hexafluoro-1,3-dioxolane and cyclopropane or dimethyl ether; 2,2,3,4,4-pentafluorooxetane and difluoromethyl (tr...
|
|
WO/1994/026690A1 |
The present invention concerns bis(aminophenoxy)-alpha-substituted stilbenes represented by Formula (I) wherein each R is independently hydrogen or a hydrocarbyl or hydrocarbyloxy group having from one to about 10, preferably one to abou...
|
|
WO/1994/023834A1 |
The solid catalyst based on amorphous particulate silica comprising titanium (IV), and showing in ultraviolet reflection spectography an absorption band at about 240 nm, is characterized in that the titanium is present in the catalyst in...
|
|
WO/1994/022848A1 |
Compounds of general structure (a) and (b) are disclosed, wherein X is O, Cn, NH, or S, wherein n is 1, 2, 3 or 4; R1 is OH, CH3, CH2OH, N3 or CH2N3; R3 is H or CH3; R5 is Y-R2, wherein Y is a six-carbon chain optionally containing up to...
|
|
WO/1994/022847A1 |
Disclosed is a process for the preparation of 3,4-dichloro- and 3,4-dibromo-1,2-epoxybutane by the reaction of 3,4-epoxy-1-butene with chlorine or bromine in the presence of a catalytic amount of a tertiary amine or a hydrohalide of a pr...
|
|
WO/1994/019338A1 |
A process for the preparation of (1S,2R)-1,2-epoxy-1,2,3,4-tetrahydronaphthalene having formula (I), which comprises the steps of (a) hydrogenating the compound of formula (II) to form c_i_s_-(1R,2S)-1,2-dihydroxy-1,2,3,4-tetrahydronapht...
|
|
WO/1994/017049A1 |
A process for producing highly pure cis-epoxysuccinic acid salt in a high yield while suppressing the amount of DL-tartaric acid salt as a by-product by epoxidizing maleic acid salt with hydrogen peroxide in the presence of an epoxidatio...
|
|
WO/1994/015901A1 |
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to membe...
|
|
WO/1994/015467A1 |
The invention disclosed is a composition for conferring low temperature tolerance to agricultural plants which comprises an effective amount of a compound having formula (I). The composition includes compounds, some of which are novel ab...
|
|
WO/1994/015986A2 |
A curable substituted resorcinol-based epoxy resin was developed having structural formula (I), wherein at least one of R1, R2 or R3 is selected from the group consisting of (a) hydrogen, (b) halogen, (c) a saturated hydrocarbon having 1...
|
|
WO/1994/015902A1 |
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to membe...
|
|
WO/1994/014436A1 |
A retroviral protease inhibiting compound of formula (A) is disclosed.
|
